Holistische kijk op de toekomst van IBD

Hoe ziet het werkveld er over een kleine 10 jaar uit? In deze podcast gaan de tafelgenoten in gesprek over de toekomst van IBD-behandeling.

U kunt de podcast direct via de player hierboven afspelen. Wilt u de aflevering liever opslaan om later te beluisteren, dan kunt u deze hier downloaden.


REFERENTIES

  1. Predicting SAE (leukopenia & pancreatitis) on azathioprine
    Shah et al, 2018. Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity. Drug Metab Pers Ther. 2018 Mar 28;33(1):57-60
  2. Al-Judaibi et al, 2016. Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease. J Popul Ther Clin Pharmacol. 2016;23(1):e26-36
    E-health developments (IBDcoach – Lancet) & IBDREAM
    http://www.dreamregistry.nl/nl/registers/inflammatory-bowel-disease
    https://www.mijnibdcoach.nl/Login.aspx?ReturnUrl=%2f
  3. Anti-inflammatory diet
    Molendijk et al, 2019. Towards a Food Pharmacy: Immunologic Modulation through Diet. Nutrients. 2019 May 31;11(6). pii: E1239
  4. Role of dietary fibers in the production of butyrate & benefits of butyrate
    Venegas et al, 2019. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol. 2019 Mar 11;10:277
  5. Home calprotectin tests
    Young-Ho, 2018. Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases. Intest Res. 2018 Oct; 16(4): 507–508
  6. VARSITY
    Sands BE, et al. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. N Engl J Med. 2019 Sep 26;381(13):1215-1226.
  7. Microbiome & FMT in UC
    Kellermayer, 2019. Fecal microbiota transplantation: great potential with many challenges. Transl Gastroenterol Hepatol. 2019 May 25;4:40